NCT06956014ClinicalTrials.gov
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy
In brief
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not…
Phase 3810 participants sought43 sites1 country
Categories
Registered in 1 registry
- ClinicalTrials.govNCT06956014Open this record at ClinicalTrials.govSynced 2 days ago
One study can be registered in several registries. We show it once and link every record we hold.
Trial information is shown as published by the registry, in its original language.
Interested in this study?
Sign in or create an account to register your interest and follow this study.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2025-05-02; recorded start 2026-09-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Vertanical GmbH)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
- Intervention regulatory context: investigational, within a phased regulatory pathway.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a phase 3 study, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding20/20
Quadruple-blind
- Control arm13/15
Placebo / sham control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre0/8
Single site, or site count not stated
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 810 participants (target), run at 43 sites.
How this score is built
- Enrolment29/40
810 participants (target)
- Site count0/25
Site count not stated in the record
- Country count0/15
Country count not stated in the record
- Planned duration7/10
Planned over about 24 months
- Sponsor scale1/10
Vertanical GmbH has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Summary
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.
Conditions
- Lumbosacral Radiculopathy
Eligibility
| Sex | All |
|---|---|
| Ages | 18 Years – No maximum |
| Healthy volunteers | No |
Eligibility as written in the registry
Eligibility in plain statements
This record's criteria have not been broken into separate statements yet. The registry text above is complete and is the authoritative version.
Study design
| Study type | Interventional |
|---|---|
| Phase | Phase 3 |
| Allocation | Randomised |
| Intervention model | PARALLEL |
| Primary purpose | TREATMENT |
| Masking | QUADRUPLE (4) |
| Enrolment | 810 participants sought |
Sponsor and collaborators
- Vertanical GmbH Sponsor
Arms and interventions
- VER-01 Dose 1EXPERIMENTAL
- VER-01 Dose 2EXPERIMENTAL
- PlaceboPLACEBO_COMPARATOR
Interventions
- Other Placebo
Comparator without active ingredient
- Drug VER-01
Standardized soft extract from Cannabis sativa DKJ127 L., cannabis flos (Cannabis flower), corresponding to 19 mg Δ9-Tetrahydrocannabinol (THC) per ml drug product
Outcome measures
Primary outcome
Efficacy based on pain reduction
The primary endpoint is the absolute change in mean leg pain intensity in the index leg measured on an 11-point numerical rating scale (NRS) at Treatment Week 12 compared to Baseline.
Time frame From Baseline to Treatment Week 12
Dates
| Start date | September 22, 2026 (actual) |
|---|---|
| Primary completion | September 1, 2028 (estimated) |
| Completion | September 1, 2028 (estimated) |
| First posted | May 2, 2025 (actual) |
| Last updated | November 19, 2026 |
| Results posted | Not stated in the registry record |
| Status last verified | November 2026 |
Actual means the event happened. Estimated means the sponsor expects it. The two mean different things.
Locations
43 sites are recruiting
United States
| Facility | City | State or region | Status |
|---|---|---|---|
| Central Texas Clinical Research, LLC | Austin | Texas | Recruiting |
| Boston Clinical Trials | Boston | Massachusetts | Recruiting |
| Bradenton Research Center | Bradenton | Florida | Recruiting |
| DFW Clinical Trials | Carrollton | Texas | Recruiting |
| Epic Medical Research - Carrolton | Carrollton | Texas | Recruiting |
| Clinitiative - Clinical Trials of South Carolina - Charleston | Charleston | South Carolina | Recruiting |
| Epic Medical Research - Chickasha | Chickasha | Oklahoma | Recruiting |
| Velocity Clinical Research - Cleveland | Cleveland | Ohio | Recruiting |
| Epic Medical Research - DeSoto | DeSoto | Texas | Recruiting |
| Mountain View Clinical Research | Denver | Colorado | Recruiting |
| Innovare Research Group I | Friendswood | Texas | Recruiting |
| AGA Clinical Trials | Hialeah | Florida | Recruiting |
| HD Research - Memorial Hermann Village | Houston | Texas | Recruiting |
| Perfizien Clinical Research LLC | Houston | Texas | Recruiting |
| Synergy Groups Medical - Southeast Houston | Houston | Texas | Recruiting |
| Green Leaf Clinical Trials | Jacksonville | Florida | Recruiting |
| R & H Clinical Research | Katy | Texas | Recruiting |
| Alliance for Multispecialty Research - Knoxville | Knoxville | Tennessee | Recruiting |
| Epic Clinical Research - Lewisville | Lewisville | Texas | Recruiting |
| Central Medical Research Institute | Long Beach | California | Recruiting |
| Tekton Research - Longmont | Longmont | Colorado | Recruiting |
| K2 Medical Research - Maitland II | Maitland | Florida | Recruiting |
| Velocity Clinical Research - Medford | Medford | Oregon | Recruiting |
| Alma Clinical Research | Miami | Florida | Recruiting |
| Floridian Research Institute LLC I | Miami | Florida | Recruiting |
| AMR Mobile | Mobile | Alabama | Recruiting |
| Monroe Biomedical Research - Monroe | Monroe | North Carolina | Recruiting |
| Alliance for Multispecialty Research - Norfolk | Norfolk | Virginia | Recruiting |
| Conquest Research - Lake Nona | Orlando | Florida | Recruiting |
| Alfa Medical Research - Pembroke Pines | Pembroke Pines | Florida | Recruiting |
| Flourish Research - Philadelphia | Plymouth Meeting | Pennsylvania | Recruiting |
| United Medical Research | Port Orange | Florida | Recruiting |
| Boeson Research | Provo | Utah | Recruiting |
| CenExel JBR - Salt Lake City | Salt Lake City | Utah | Recruiting |
| Elixia Clinical Research Collaborative | Springfield | Massachusetts | Recruiting |
| Professional Health Care of Pinellas | St. Petersburg | Florida | Recruiting |
| Velocity Clinical Research - Suffolk | Suffolk | Virginia | Recruiting |
| Alliance for Multispecialty Research - Tempe I | Tempe | Arizona | Recruiting |
| Alliance for Multispecialty Research - Wichita East | Wichita | Kansas | Recruiting |
| Grayline Research Center | Wichita Falls | Texas | Recruiting |
| Progressive Medicine of the Triad, LLC | Winston-Salem | North Carolina | Recruiting |
| Conquest Research - Winter Park | Winter Park | Florida | Recruiting |
| Vitalix Clinical | Worcester | Massachusetts | Recruiting |
Study documents
No documents are linked in this registry record.
Changes over time
- November 19, 2026
Site added
11 sites added (43 total)
3243
- November 2, 2026
Site added
9 sites added (32 total)
2332
- October 21, 2026
Site added
1 site added (23 total)
2223
- October 19, 2026
Site added
21 sites added (22 total)
122
- September 28, 2026
Status changed
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- September 28, 2026
Site added
1 site added (1 total)
01
- September 28, 2026
Recruitment opened
Recruitment opened
NOT_YET_RECRUITINGRECRUITING